Chemotherapy News and Research

Latest Chemotherapy News and Research

New mechanism that contributes to the development of some breast and ovarian cancers

Researchers at Mount Sinai School of Medicine have discovered a new mechanism of activation of a pathway known to be implicated in many cancers.

23 Nov 2004

FDA approves Tarceva (erlotinib)

OSI Pharmaceuticals and Genentech have announced that the U.S. Food and Drug Administration (FDA) has approved, after priority review, Tarceva (erlotinib) for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) after failure of at least one prior chemotherapy regimen.

20 Nov 2004

More clinical trials needed to evaluate the benefits of complementary therapies for cancer patients

Prof Leslie Walker says that many people benefit from relaxation therapy, hypnotherapy and guided imagery in which patients are taught to visualise their bodies' defences vanquishing tumours and promoting good health.

18 Nov 2004

New genetic test has proven useful as a prognostic tool for ovarian cancer

The identification of a gene expression profile using microarray technology may help clinicians better determine the prognosis of patients with advanced stage ovarian cancer and may eventually help provide targeted therapies for this hard-to-treat disease, according to a study led by investigators at Beth Israel Deaconess Medical Center (BIDMC).

18 Nov 2004

Generic antipsychotic drugs can protect brain cells from progressive multifocal leukoencephalopathy

Generic antipsychotic drugs can protect brain cells from a virus that causes a fatal nervous system disorder, according to research conducted at Brown University and Case Western Reserve University.

18 Nov 2004

Combining radiation therapy with surgery and chemotherapy helps patients with rare forms of thyroid cancer live longer

Combining radiation therapy with surgery and chemotherapy helps patients with rare forms of thyroid cancer live longer, according to a study published in the November 15, 2004, issue of the International Journal of Radiation Oncology~Biology~Physics, the official journal of ASTRO, the American Society for Therapeutic Radiology and Oncology.

16 Nov 2004

36% of cancer patients ages 65 and older participate in clinical trials

A new study finds that only 36% of cancer patients ages 65 and older participate in clinical trials, despite making up 60% of the U.S. cancer population. The study will be published November 15 in the Journal of Clinical Oncology (JCO).

14 Nov 2004

Lorus Therapeutics allowed Canadian patent to protect anticancer drugs

Lorus Therapeutics today announced that its wholly owned subsidiary, GeneSense Technologies Inc., has been allowed a patent by the Canadian Patent Office entitled "Antitumor Antisense Sequences Directed Against R1 and R2 Components of Ribonucleotide Reductase."

10 Nov 2004

Impaired cognitive and motor function following stem cell transplantation for severe blood disorders can improve

Patients who suffer a loss of cognitive and motor function as a result of stem cell transplantation for severe blood disorders are likely to see those functions return to previous levels after one year, according to a new study in the November 15, 2004, issue of Blood, the official journal of the American Society of Hematology.

8 Nov 2004

Researchers have documented a novel form of resistance in leukemia cells to an anti-cancer drug

Researchers at Virginia Commonwealth University’s Massey Cancer Center have documented a novel form of resistance in leukemia cells to an anti-cancer drug, which could help scientists develop new strategies for treating the disease.

8 Nov 2004

MRI technique for measuring blood volume helps distinguish between abscesses and tumors in the brain

Dynamic susceptibility contrast (DSC) MRI allows physicians to differentiate between cerebral abscesses—inflamed areas in the brain caused by infection—and malignant brain tumors without surgery, says a new preliminary study by researchers from Duke University Medical Center in Durham, NC.

8 Nov 2004

Testosterone may impede immunity

Decreasing testosterone boosts immunity because testosterone helps control T-lymphocytes, the attack cells of the immune system, according to Mayo Clinic-led research in laboratory animals.

8 Nov 2004

Second successful human ovarian to arm transplant in the world

A new study finds surgery to transplant an ovary to the upper arm is feasible and preserves hormonal function in women undergoing treatment for cervical cancer.

8 Nov 2004

Cellular vehicle delivers drugs directly into cancer cells

Researchers at The University of Texas M. D. Anderson Cancer Center have perfected a delivery system for anticancer treatment that zeroes in on a tumor and becomes part of its supporting tissue.

4 Nov 2004

Sperm cells grown in laboratory culture

A team of researchers working with cells from mice has overcome a technical barrier and succeeded in growing sperm progenitor cells in laboratory culture.

4 Nov 2004

Researchers identify biomarkers that could lead to more accurate diagnosis of systemic lupus erythematosus

University of Pittsburgh researchers have identified biomarkers that could result in earlier and more accurate diagnosis of systemic lupus erythematosus (SLE), a devastating disease that affects as many as 1.5 million Americans, and occurs 10 to 15 times more frequently in women.

4 Nov 2004

Cyclooxygenase (COX) inhibitors tested in both prevention and treatment clinical trials

Numerous compounds are examined by the National Cancer Institute (NCI) for their potential to prevent or treat cancer. One class of compounds, cyclooxygenase (COX) inhibitors, is currently being tested in both prevention and treatment clinical trials.

4 Nov 2004

FDA fast tracks investigational anti-cancer drug, phenoxodiol

Marshall Edwards today announced that the U.S. Food and Drug Administration (FDA) has granted the investigational anti-cancer drug, phenoxodiol, Fast Track status for its intended use in patients with recurrent ovarian cancer.

4 Nov 2004

The Bush Medicare Prescription has changed the identity of medical oncology

Under previous law, Medicare covered chemotherapy as well as radiation treatment for cancer patients, but did not pay for oral-dose anti-cancer drugs, unless they were available in both oral and injectable form.

4 Nov 2004

European approval for Taxotere (docetaxel) in prostate cancer

Aventis, part of the sanofi-aventis Group announced today that the European Commission has approved Taxotere (docetaxel) Injection Concentrate for use in combination with prednisone as a treatment for men with androgen-independent (hormone- refractory) metastatic prostate cancer.

4 Nov 2004

Chemotherapy News and Research

Latest Chemotherapy News and Research

New mechanism that contributes to the development of some breast and ovarian cancers

FDA approves Tarceva (erlotinib)

More clinical trials needed to evaluate the benefits of complementary therapies for cancer patients

New genetic test has proven useful as a prognostic tool for ovarian cancer

Generic antipsychotic drugs can protect brain cells from progressive multifocal leukoencephalopathy

Combining radiation therapy with surgery and chemotherapy helps patients with rare forms of thyroid cancer live longer

36% of cancer patients ages 65 and older participate in clinical trials

Lorus Therapeutics allowed Canadian patent to protect anticancer drugs

Impaired cognitive and motor function following stem cell transplantation for severe blood disorders can improve

Researchers have documented a novel form of resistance in leukemia cells to an anti-cancer drug

MRI technique for measuring blood volume helps distinguish between abscesses and tumors in the brain

Testosterone may impede immunity

Second successful human ovarian to arm transplant in the world

Cellular vehicle delivers drugs directly into cancer cells

Sperm cells grown in laboratory culture

Researchers identify biomarkers that could lead to more accurate diagnosis of systemic lupus erythematosus

Cyclooxygenase (COX) inhibitors tested in both prevention and treatment clinical trials

FDA fast tracks investigational anti-cancer drug, phenoxodiol

The Bush Medicare Prescription has changed the identity of medical oncology

European approval for Taxotere (docetaxel) in prostate cancer

Cancer Research - Second Edition eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in